Aduro Biotech (ADRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADRO | BMY | AMGN | GILD | ILMN |
| Company | Aduro Biotech | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.05 | 49.29 | 335.15 | 83.26 | 133.64 |
| High | 14.86 | 49.53 | 338.97 | 83.96 | 133.64 |
| Low | 13.92 | 49.00 | 334.27 | 82.75 | 130.36 |
| Last | 14.60 | 49.29 | 338.02 | 83.16 | 132.07 |
| Change | +0.59 | +0.27 | +2.07 | -0.74 | -2.32 |
| % Change | +4.18% | +0.55% | +0.62% | -0.88% | -1.73% |
| Volume | 171,500 | 10,060,895 | 2,140,731 | 8,188,276 | 663,365 |
| 20-Day Average Volume | 149,894 | 8,605,270 | 1,756,578 | 6,798,436 | 1,334,500 |
| Previous Close | 14.01 | 49.02 | 335.95 | 83.90 | 134.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.53 | 49.17 | 330.23 | 80.43 | 129.32 |
| 20-Day Raw Stochastic | 76.03% | 52.52% | 92.30% | 78.79% | 71.91% |
| 20-Day Relative Strength | 56.92% | 54.68% | 58.82% | 67.36% | 56.76% |
| Weighted Alpha | +96.00 | -10.88 | +27.88 | +16.46 | +5.60 |
| Today's Opinion | 40% Buy | 56% Buy | 100% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 32% Buy | 56% Buy | 96% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 56% Buy | 40% Buy | 88% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.16% since 09/28/20 | +0.04% since 09/13/24 | +1.51% since 09/13/24 | +0.21% since 09/13/24 | +2.02% since 09/13/24 |
| Low | 11.30 on 10/02/20 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 127.50 on 09/16/24 |
| High | 15.73 on 10/02/20 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +9.74% since 09/04/20 | +0.35% since 08/20/24 | +2.71% since 08/20/24 | +11.02% since 08/20/24 | -0.55% since 08/20/24 |
| Low | 11.00 on 09/24/20 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 120.51 on 09/12/24 |
| High | 15.73 on 10/02/20 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | +16.76% since 07/02/20 | +19.76% since 06/20/24 | +8.90% since 06/20/24 | +21.16% since 06/20/24 | +21.74% since 06/20/24 |
| Low | 11.00 on 09/24/20 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 103.52 on 06/28/24 |
| High | 17.20 on 08/18/20 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +14.92% since 04/03/20 | -5.26% since 03/20/24 | +23.59% since 03/20/24 | +12.17% since 03/20/24 | -1.05% since 03/20/24 |
| Low | 10.50 on 06/26/20 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 100.08 on 05/30/24 |
| High | 17.70 on 05/28/20 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 236,614 | 99,368,440 | 180,215,344 | 104,527,072 | 21,408,328 |
| Shares Outstanding, K | 16,212 | 2,027,100 | 536,435 | 1,245,853 | 159,300 |
| Annual Sales | 17,260,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -82,370,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 5,570,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -16,620,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -1,988,000,000 |
| 60-Month Beta | 0.40 | 0.46 | 0.61 | 0.18 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/05/20 | 10/31/24 | 10/29/24 | 11/05/24 | 08/06/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 142.36 |